Jazz Pharmaceuticals (JAZZ) Insider Trading & Ownership $124.27 -3.38 (-2.65%) (As of 11/14/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Jazz Pharmaceuticals (NASDAQ:JAZZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.44 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.57 M Get JAZZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Jazz Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address JAZZ Insider Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Jazz Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/8/2024Neena M PatilEVPSell3,700$123.41$456,617.00 11/1/2024Bruce C CozaddCEOSell1,000$110.84$110,840.00 9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.00 6/7/2024Patricia CarrCAOSell163$108.83$17,739.29 5/3/2024Neena M PatilEVPSell5,000$109.65$548,250.00 3/6/2024Patricia CarrCAOSell1,936$119.64$231,623.04 3/1/2024Philip L JohnsonCFOBuy12,000$119.65$1,435,800.00 12/4/2023Mark Douglas SmithDirectorSell417$119.27$49,735.59 (Data available from 1/1/2013 forward) JAZZ Insider Trading Activity - Frequently Asked Questions Who is on Jazz Pharmaceuticals's Insider Roster? The list of insiders at Jazz Pharmaceuticals includes Anne Oriordan, Bruce C Cozadd, Christopher J Tovey, Finbar Larkin, Jennifer E Cook, Kenneth W O'keefe, Kim Sablich, Mark Douglas Smith, Mary Elizabeth Henderson, Neena M Patil, Patricia Carr, Patrick G Enright, Peter Gray, Philip L Johnson, Renee D Gala, Rick E Winningham, Robert Iannone, and Samantha Pearce. Learn more on insiders at JAZZ. What percentage of Jazz Pharmaceuticals stock is owned by insiders? 4.20% of Jazz Pharmaceuticals stock is owned by insiders. Learn more on JAZZ's insider holdings. Which Jazz Pharmaceuticals insiders have been buying company stock? The following insider purchased JAZZ shares in the last 24 months: Philip L Johnson ($1,435,800.00). How much insider buying is happening at Jazz Pharmaceuticals? Insiders have purchased a total of 12,000 JAZZ shares in the last 24 months for a total of $1,435,800.00 bought. Which Jazz Pharmaceuticals insiders have been selling company stock? The following insiders have sold JAZZ shares in the last 24 months: Bruce C Cozadd ($903,210.00), Finbar Larkin ($274,945.53), Jennifer E Cook ($64,965.60), Kenneth W O'keefe ($372,269.10), Kim Sablich ($421,036.62), Mark Douglas Smith ($49,735.59), Mary Elizabeth Henderson ($152,703.00), Neena M Patil ($1,530,702.50), Patricia Carr ($615,138.59), Patrick G Enright ($743,513.52), Renee D Gala ($1,212,100.00), Rick E Winningham ($171,456.56), Robert Iannone ($279,439.76), and Samantha Pearce ($167,286.24). How much insider selling is happening at Jazz Pharmaceuticals? Insiders have sold a total of 50,918 Jazz Pharmaceuticals shares in the last 24 months for a total of $6,958,502.61 sold. Jazz Pharmaceuticals Key ExecutivesMr. Bruce C. Cozadd (Age 60)Co-Founder, Chairman & CEO Compensation: $2.44M1 recent tradesMs. Renee D. Gala (Age 52)President & COO Compensation: $1.36MMs. Patricia Carr (Age 53)Senior VP & Chief Accounting Officer Compensation: $633.4k1 recent tradesMs. Neena M. Patil J.D. (Age 49)Executive VP & Chief Legal Officer Compensation: $1.01M1 recent tradesDr. Robert Iannone M.D. (Age 57)Executive VP, Chief Medical Officer and Global Head of Research & Development Compensation: $1.19MMr. Philip L. Johnson (Age 60)Executive VP & CFO Ms. Andrea N. Flynn Ph.D.VP & Head of Investor RelationsMs. Heidi Manna (Age 53)Executive VP & Chief People Officer Dr. Jed Black M.D.Senior Vice President of Sleep & CNS MedicineMs. Samantha Pearce (Age 58)Executive VP & Chief Commercial OfficerChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Ultragenyx Pharmaceutical Insider Transactions Bausch Health Companies Insider Transactions ACADIA Pharmaceuticals Insider Transactions Arrowhead Pharmaceuticals Insider Transactions Royalty Pharma Insider Transactions Corcept Therapeutics Insider Transactions Perrigo Insider Transactions Supernus Pharmaceuticals Insider Transactions Pacira BioSciences Insider Transactions Omeros Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:JAZZ) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.